Zdrowie i gospodarka · 14/06/1996
FDA Proposes Classification of Immunohistochemistry Reagents and Kits
The FDA is proposing to categorize immunohistochemistry reagents and kits into three classes based on their intended use, aiming to regulate these devices uniformly under the Federal Food, Drug, and Cosmetic Act.
Source: Federal Register — Food and Drug AdministrationOpen original release →